B. Paul Morgan

39.2k total citations
620 papers, 28.1k citations indexed

About

B. Paul Morgan is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, B. Paul Morgan has authored 620 papers receiving a total of 28.1k indexed citations (citations by other indexed papers that have themselves been cited), including 366 papers in Immunology, 115 papers in Molecular Biology and 101 papers in Hematology. Recurrent topics in B. Paul Morgan's work include Complement system in diseases (321 papers), Monoclonal and Polyclonal Antibodies Research (70 papers) and Erythrocyte Function and Pathophysiology (69 papers). B. Paul Morgan is often cited by papers focused on Complement system in diseases (321 papers), Monoclonal and Polyclonal Antibodies Research (70 papers) and Erythrocyte Function and Pathophysiology (69 papers). B. Paul Morgan collaborates with scholars based in United Kingdom, United States and Netherlands. B. Paul Morgan's co-authors include Claire L. Harris, Philippe Gasque, Anthony K. Campbell, Carmen W. van den Berg, Sim K. Singhrao, Santiago Rodrı́guez de Córdoba, James Neal, Seppo Meri, D. A. S. Compston and Sara J. Piddlesden and has published in prestigious journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

B. Paul Morgan

594 papers receiving 27.5k citations

Peers

Countries citing papers authored by B. Paul Morgan

Since Specialization

Citations

This map shows the geographic impact of B. Paul Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Paul Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Paul Morgan more than expected).

Fields of papers citing papers by B. Paul Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Paul Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Paul Morgan. The network helps show where B. Paul Morgan may publish in the future.

Co-authorship network of co-authors of B. Paul Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of B. Paul Morgan. A scholar is included among the top collaborators of B. Paul Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Paul Morgan. B. Paul Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans 2025 ·Brain Behavior and Immunity ·(unknown), (unknown), Megan Torvell, Sarah M. Carpanini, Nikoleta Daskoulidou, Timothy R. Hughes, Linda J. Noble‐Haeusslein, (unknown), Lewis M. Watkins, Wioleta M. Zelek, Michael O’Donovan, B. Paul Morgan	2
2	The Alzheimer’s disease-associated complement receptor 1 variant CR12 enhances glial phagocytosis of relevant targets and impacts neuroinflammation 2025 ·Immunobiology* ·Nikoleta Daskoulidou, (unknown), Wioleta M. Zelek, B. Paul Morgan	0
3	Novel anti-clusterin monoclonals as tools for characterising clusterin expression in biofluids and tissues 2025 ·Immunobiology ·(unknown), (unknown), (unknown), (unknown), Molly G. Bright, (unknown), Nikoleta Daskoulidou, Kitack Lee, Wioleta M. Zelek, B. Paul Morgan	0
4	Profiling complement dysregulation in frontotemporal dementia using cerebrospinal fluid, plasma, and exosomes 2025 ·Immunobiology ·Lewis M. Watkins, (unknown), (unknown), (unknown), (unknown), B. Paul Morgan, Aitana Sogorb‐Esteve, Wioleta M. Zelek	0
5	Development of a novel dual fluorescent ELISA (FELISA) for the simultaneous quantification of C3 and C3a in biological fluids 2025 ·Immunobiology ·(unknown), Wioleta M. Zelek, B. Paul Morgan	0
6	C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disorders 2025 ·Immunobiology ·(unknown), (unknown), (unknown), (unknown), Molly G. Bright, (unknown), (unknown), (unknown), (unknown), John T. O’Brien, James B. Rowe, B. Paul Morgan, Maura Malpetti, Wioleta M. Zelek	0
7	A multi-omic pipeline identifies complement as a driver of age-dependent progression in a model of multiple sclerosis 2025 ·Immunobiology ·Kevin Champagne-Jorgensen, (unknown), Judy Zhu, Jitendra Patel, Ikbel Naouar, Michelle Zuo, Alexandra Florescu, (unknown), Michal Goldberg, (unknown), Cassandra J. Wong, Zhen‐Yuan Lin, Anne‐Claude Gingras, B. Paul Morgan, Jennifer L. Gommerman, Valeria Ramaglia	0
8	Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI 2025 ·Blood ·(unknown), (unknown), Xiuzhang Xu, Wenjie Xia, Xin Ye, (unknown), Jiansen He, (unknown), Jing Liu, Hui Ren, (unknown), Trent M. Woodruff, Wioleta M. Zelek, B. Paul Morgan, Rick Kapur, Sentot Santoso, Yongshui Fu	0
9	The Alzheimer's disease‐associated complement receptor 1 variant confers risk by impacting glial phagocytosis 2025 ·Alzheimer s & Dementia ·Nikoleta Daskoulidou, (unknown), Wioleta M. Zelek, B. Paul Morgan	3
10	Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats 2024 ·Journal of Medicinal Chemistry ·Scott E. Collibee, (unknown), Alexander R. Muci, Darren T. Hwee, Chih-Yuan Chuang, James J. Hartman, Alykhan Motani, (unknown), (unknown), Mark P. Grillo, (unknown), Fady I. Malik, B. Paul Morgan	2
11	Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Scott E. Collibee, Chih-Yuan Chuang, James J. Hartman, Darren T. Hwee, (unknown), Justin T. Malinowski, (unknown), (unknown), (unknown), (unknown), (unknown), Alykhan Motani, (unknown), Fady I. Malik, B. Paul Morgan	6
12	Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation 2022 ·Brain Pathology ·L Rossini, (unknown), (unknown), Cinzia Cagnoli, Emanuela Maderna, Daniele Cartelli, B. Paul Morgan, Megan Torvell, Roberto Spreafico, Roberta Di Giacomo, Laura Tassi, Marco de Curtis, Rita Garbelli	12
13	Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorder 2021 ·Brain Behavior and Immunity ·Laura J. Westacott, Trevor Humby, Niels Haan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael J. Owen, Jérémy Hall, Timothy R. Hughes, B. Paul Morgan, William Gray, Lawrence S. Wilkinson	18
14	Temporal development and neutralising potential of antibodies against SARS-CoV-2 in hospitalised COVID-19 patients: An observational cohort study 2021 ·PLoS ONE ·Isa Murrell, (unknown), Wioleta M. Zelek, (unknown), (unknown), Nicki Palmer, Rachel Jones, B. Paul Morgan, Catherine Moore	9
15	Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration 2020 ·Nature Communications ·Valentina Cipriani, Laura Lorés‐Motta, (unknown), Dina Fathalla, Viranga Tilakaratna, Selina McHarg, Nadhim Bayatti, İlhan E. Acar, Carel B. Hoyng, Sascha Fauser, Anthony T. Moore, John R.W. Yates, Eiko K. de Jong, B. Paul Morgan, Anneke I. den Hollander, Richard D. Unwin, Simon J. Clark	82
16	Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa 2019 ·Journal of Investigative Dermatology ·Mondana Ghias, Michael J. Hyde, Lewis E. Tomalin, B. Paul Morgan, Afsáneh Alavi, Michelle A. Lowes, Vincent Piguet	27
17	Autoantibodies to CD59, CD55, CD46 and CD35 are not associated with aHUS 2014 ·Molecular Immunology ·Sophie Ward, (unknown), (unknown), (unknown), Paula Bertram, Arthur Jackson, Catriona E. Barker, (unknown), David Kavanagh, Susan M. Lea, B. Paul Morgan, (unknown), (unknown), Kevin J. Marchbank	1
18	Impaired Binding of the Amd-Associated Complement Factor H 402h Allotype to Bruch’s Membrane in Human Retina 2010 ·Investigative Ophthalmology & Visual Science ·Simon J. Clark, Rahat Perveen, (unknown), B. Paul Morgan, Robert B. Sim, Anthony J. Day, Richard D. Unwin	1
19	Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome 2006 ·Proceedings of the National Academy of Sciences ·Elena Goicoechea de Jorge, Claire L. Harris, Jorge Esparza-Gordillo, L Carreras, (unknown), (unknown), Margarita López‐Trascasa, Pilar Sánchez‐Corral, B. Paul Morgan, Santiago Rodrı́guez de Córdoba	348
20	Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis 1997 ·Clinical & Experimental Immunology ·Rhian Goodfellow, Anwen S. Williams, J. L. Levin, Bryan Williams, B. Paul Morgan	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact